Current status and future prospects of protein vaccine candidates against Schistosoma mansoni infection
Schistosomiasis is an acute and chronic tropical parasitic disease caused by blood dwelling worm of the genus Schistosoma. It is the most destructive disease globally and is a major cause of morbidity and mortality for developing countries. Three main species of schistosomes infect human beings from...
Main Authors: | Tahir Eyayu, Ayalew Jejaw Zeleke, Ligabaw Worku |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-11-01
|
Series: | Parasite Epidemiology and Control |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405673120300453 |
Similar Items
-
Adjuvanted Schistosoma mansoni-Cathepsin B With Sulfated Lactosyl Archaeol Archaeosomes or AddaVax™ Provides Protection in a Pre-Clinical Schistosomiasis Model
by: Dilhan J. Perera, et al.
Published: (2020-11-01) -
A low dose adenovirus vectored vaccine expressing Schistosoma mansoni Cathepsin B protects from intestinal schistosomiasis in mice
by: Elahi, S.M, et al.
Published: (2022) -
Pathogenesis of Schistosoma mansoni infection
by: Allen W. Cheever
Published: (1992-01-01) -
Estudo morfológico de Schistosoma mansoni pertencentes a linhagens de Belo Horizonte (MG) e de São José dos Campos (SP) Morphologic studies of Schistosoma mansoni strains from Belo Horizonte MG and S. José dos Campos, SP (Brazil)
by: Luiz A. Magalhães, et al.
Published: (1973-09-01) -
Evaluation of the Schistosoma mansoni Y-box-binding protein (SMYB1) potential as a vaccine candidate against schistosomiasis
by: Silvia Regina Costa Dias, et al.
Published: (2014-06-01)